Potential of Long-Acting Products to Transform the Treatment and Prevention of Human Immunodeficiency Virus (HIV) in Infants, Children, and Adolescents

Abrams, E. J., Capparelli, E., Ruel, T., & Mirochnick, M. (2022). Potential of Long-Acting Products to Transform the Treatment and Prevention of Human Immunodeficiency Virus (HIV) in Infants, Children, and Adolescents. Clinical Infectious Diseases, 75(Supplement_4), S562–S570. https://doi.org/10.1093/cid/ciac754
Authors:
Elaine J. Abrams
Edmund Capparelli
Theodore Ruel
Mark Mirochnick
Affiliated Authors:
Elaine J. Abrams
Columbia Affiliation:
Subjects:
HIV Infections (MeSH)
Author Keywords:
long-acting antiretroviral agents
pediatrics
neonatal physiology
adherence
elink
Publication Type:
Article
Unique ID:
10.1093/cid/ciac754
PMID:
36410381
DOI:
10.1093/cid/ciac754
Journal:
Clinical Infectious Diseases
Publication Date:
Data Source:
Scopus
Source Link:
View Scopus Record
View PubMed Record
View Web of Science Record

Record Created: